Sienna Biopharmaceuticals, Inc. Share Price
Equities
SNNAQ
US82622H1086
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
Sales 2017 | - | Sales 2018 | - | Capitalization | 48.12M 3.84B |
---|---|---|---|---|---|
Net income 2017 | -50M -3.99B | Net income 2018 | -73M -5.82B | EV / Sales 2017 | - |
Net cash position 2017 | 74.47M 5.94B | Net cash position 2018 | 18.4M 1.47B | EV / Sales 2018 | - |
P/E ratio 2017 |
-3.5
x | P/E ratio 2018 |
-0.65
x | Employees | 13 |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 99.54% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 26/06/10 | |
Majed Kheir
COO | Chief Operating Officer | 46 | 31/12/15 |
Silvio Traversa
CTO | Chief Tech/Sci/R&D Officer | 54 | 30/11/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Fenton
BRD | Director/Board Member | 72 | 30/09/16 |
Founder | 59 | 26/06/10 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 22 | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+2.47% | 22.18B | |
-16.67% | 21.2B | |
-9.21% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- SNNAQ Stock